Healthcare Industry News: Seal-N-Cut
News Release - December 23, 2009
Bovie Medical Corporation Announces FDA 510(k) Clearance to Market Resistick II Coated Electrodes
MELVILLE, N.Y.--(HSMN NewsFeed)--Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company has received 510(k) clearance from the Food and Drug Administration (FDA) to market its line of coated blades, needles and ball electrodes used for cutting and coagulating soft tissues during surgical procedures. Resistick II is coating applied to stainless steel which resists eschar (scab or scar tissue caused by burning) during surgery. The coated electrodes continue the expansion of the Bovie line of electrosurgical disposables.Current applications still pending at the FDA include the BOSS soft tissue coagulation device, the Seal-N-Cut vessel sealing instrument line and the ICON VS (vessel sealing) generator.
For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie’s website www.boviemedical.com.
This document may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company’s SEC filings.
Source: Bovie Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
